Peter Lamb, EVP, Scientific Strategy & CSO at EXELIXIS, INC. (EXEL), sold 55,192 shares at $20.03 ($1.1M) on 2019-06-13, disclosed to the SEC on 2019-06-14.
Open-market sale of $1.1M EXEL by EVP, Scientific Strategy & CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.03 | 27,596 | $553K | 50.0% |
| 2 | $20.03 | 27,596 | $553K | 50.0% |
| Total | $20.03 avg | 55,192 | $1.1M | 100% |
| Filing → |
| EXEL | SELL | 2021-11-17 | $859K | — | Filing → |
| EXEL | SELL | 2021-10-15 | $2.1M | — | Filing → |
| EXEL | SELL | 2021-09-17 | $972K | — | Filing → |